Open AccessAnxiety and depression in COVID-19: treatment options
Author(s) -
В. Э. Медведев
Publication year - 2021
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 9
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2021-2-111-116
Subject(s) - anxiety , tranquilizer , antidepressant , depression (economics) , fluvoxamine , pandemic , covid-19 , adverse effect , medicine , psychiatry , psychology , clinical psychology , intensive care medicine , disease , fluoxetine , receptor , serotonin , infectious disease (medical specialty) , economics , macroeconomics